Diastolic dysfunction in patients on thyroid-stimulating hormone suppressive therapy with levothyroxine: Beneficial effect of β-blockade

Journal of Clinical Endocrinology and Metabolism

Volumn 80, Issue 7, 1995, Pages 2222-2226

  Fazio, S ^a   Biondi, B ^a   Carella, C ^b   Sabatini, D ^b   Cittadini, A ^a   Panza, N ^a   Lombardi, G ^a   Sacca L ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BISOPROLOL; LEVOTHYROXINE;

ADULT; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CARDIOTOXICITY; CLINICAL ARTICLE; DOSE TIME EFFECT RELATION; DRUG EFFECT; FEMALE; GOITER; HEART ARRHYTHMIA; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE FILLING; HEART VENTRICLE HYPERTROPHY; HUMAN; MALE; PRIORITY JOURNAL; THYROID CARCINOMA;

ADULT; BISOPROLOL; CARDIOMEGALY; COMPARATIVE STUDY; DIASTOLE; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; GOITER; HEART RATE; HEART VENTRICLE; HUMAN; MALE; MIDDLE AGE; SYSTOLE; THYROID NEOPLASMS; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 0029002415     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem.80.7.7608283     Document Type: Article

References (32)

1. Buccino RA, Spann JF, Pool PE, Sonnenblick EH, Braunwald E. 1967 Influence of thyroid state on intrinsic contractile properties a nd energy stores of myocardium. J Clin Invest. 46:1669-1682.
2. Forfar JC, Muir AL, Sawers SA, Toft AD. 1982 Abnormal left ventricular function in hyperthyroidism. N Engl J Med. 307: 1165-1170.
3. Merillon JP, Passa P, Chastre J, Wolf A, Gourgon R. 1982 Left ventricular function and hyperthyroidism. Br Heart J. 46:137-140.
4. Friedman MJ, Okada RD, Ewy GA, Heilman DJ. 1982 Left ventricular systolic and diastolic function in hyperthyroidism. Am Heart J. 104:1303-1308.
5. Klein 1.1990 Thyroid hormone and the cardiovascular system. Am J Med. 88:631-637.
6. Minz G, Pizzarello R, Klein I. 1991 Enhanced left ventricular diastolic function in hyperthyroidism: noninvasive assessment and response to treatment. J Clin Endocrinol Metab. 73:146-150.
7. Ladenson P. 1993 Thyrotoxicosis and the heart: something old and something new. Clin Endocrinol Metab. 77:332-333.
8. Biondi B, Fazio S, Carella C, et al. 1993 Cardiac effects of long-term thyrotropin-suppressive therapy with levothyroxine. J Clin Endocrinol Metab. 77:334-338.
9. Biondi B, Fazio S, Carella C, et al. 1994 Control of adrenergic overactivity by 0-blockade improves quality of life in patients receiving long-term suppressive therapy with levothyroxine. J Clin Endocrinol Metab. 78:1028-1033.
10. Gaasch WH, Levine HJ, Quinones MA, Alexander JK. 1976 Left ventricular compliance: Mechanisms and clinical implications. Am J Cardiol. 38:645-653.
11. Grossman W, McLaurin WT. 1976 Diastolic properties of the left ventricles. Ann Intern Med. 84:316-326.
12. Inouye I, Massie B, Loge D, et al. 1985 Abnormal left ventricular filling: An early finding in mild to moderate systemic hypertension. Am J Cardiol. 53:120-126.
13. Smith VE, Schulman P, Karimeddini MK, White WB, Meeran MK, Katz AM. 1985 Rapid ventricular filling in left ventricular hypertrophy. II. Pathologic hypertrophy. J Am Coll Cardiol. 5:869-874.
14. Cuocolo A, Sax FL, Brush JE, Moron BJ, Bacharach SL, Bonow RO. 1990 Left ventricular hypertrophy and impaired diastolic filling in essential hypertension. Circulation. 81:978-986.
15. Bonow RO, Udelson JE. 1992 Left ventricular diastolic dysfunction as a cause of congestive heart failure: Mechanisms and management. Ann Intern Med. 117:502-510.
16. Klein I, Trzepacz PT, Roberts M, Levey G. 1988 Symptoms rating scale for assessing hyperthyroidism. Arch Intern Med. 148:387-390.
17. Fazio S, Cittadini A, Sabatini D, et al. 1993 Evidence of biventricular involvement in acromegaly: A Doppler echocardiographic study. Eur Heart J. 14:26-33.
18. Devereux RB. 1987 Detection of left ventricular hypertrophy by M-mode echocardiography: Anatomic validation, standardization and comparison to other methods. Hypertension (Suppl 2). 9:19-26.
19. Ishida Y, Meisners JS, Tsujioka K, et al. 1986 Left ventricular filling dynamics: Influence of left ventricular relaxation and left atrial pressure. Circulation. 74:187-196.
20. Udelson JE, Bacharach SL, Cannon RO, Bonow RO. 1990 Minimum left ventricular pressure during β-adrenergic stimulation in human subjects: evidence for elastic recoil and diastolic suction in normal heart. Circulation. 82:1174-1182.
21. Smith VE, White WB, Meeran MK, Karimeddini MK. 1986 Improved left ventricular filling accompanies reduced left ventricular mass during therapy of essential hypertension. J Am Coll Cardiol. 8:1449-1454.
22. Trimarco B, De Luca N, Rosiello G, et al. 1989 Improvement of diastolic function after reversal of left ventricular hypertrophy induced by long term antihypertensive treatment with tertatolol. Am J Cardiol. 64:745-751.
23. Klein I. 1988 Thyroxine-induced cardiac hypertrophy: Time course of development and inhibition by propanolol. Endocrinology. 123: 203-210.
24. Ojama K, Samouel M, Kupfer JM, Hong C, Klein I. 1992 Thyroid hormone effects on cardiac gene expression independent of cardiac growth and protein synthesis. Am J Physiol. 263:E534-540.
25. Bedotto JB, Gay RG, Graham SD, Morkin E, Goldman S. 1989 Cardiac hypertrophy induced by thyroid hormone is independent of loading condition and 0-adrenoreceptor blockade. J Pharmacol Exp Ther. 248:632-636.
26. Rohrer D, Dilmann WH. 1988 Thyroid hormones markedly increase the mRNA coding for sarcoplasmic reticulum Ca2-ATPase in the rat heart. J Biol Chem. 263:6941-6944.
27. Suko J. 1973 The calcium pump of cardiac sarcoplasmatic reticulum: Functional alterations at different levels of thyroid state in rabbits. J Physiol. 228:563-582.
28. Jennings PO, O'Malley BP, Griffin KE, Northoven B, Rosenthal FD. 1984 Relevance of increased serum triiodo-thyroxine values in hypothyroid patients receiving thyroxine: A case for "tissue thyrotoxicosis." Br Med J. 289:1645-1647.
29. Grand FM, Niewoehner CB. 1989 Hyperthyroidism in patients receiving thyroid replacement therapy. Arch Intern Med. 149: 921-929.
30. De Groot LJ, Kaplan E, Me Cormick M, Straus FH. 1990 Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab. 71:414-424.
31. Hay ID. 1990 Papillary thyroid carcinoma. Endocrinol Metab Clin North Am. 19:545-576.
32. Mandel SJ, Brent G, Larsen PR. 1993 Levothyroxine therapy in patients with thyroid disease. Ann Intern Med. 119:492-502.